Frequency of Fatty Liver in Patients Presenting with Acute Pancreatitis and Its Association with Disease Severity

Authors

  • Mahrukh Naeem Kakar Radiology Department, Bolan Medical Complex Hospital, Quetta, Balochistan, Pakistan.
  • Asad Khan Tareen Urology Department, Sandeman Provincial Hospital, Quetta, Balochistan, Pakistan.
  • Rizwana Kakar Radiology Department, Bolan Medical Complex Hospital, Quetta, Balochistan, Pakistan.
  • Muhammad Irfan Jamil Nephrology Department, Lahore General Hospital, Lahore, Punjab, Pakistan.
  • Shazia Bano Radiology Department, CMH Multan, Punjab, Pakistan.
  • Sadaf Aziz Radiology Department, CMH Lahore Medical College, Lahore, Punjab, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i5.2102

Keywords:

Acute Pancreatitis, Non-Alcoholic Fatty Liver Disease (NAFLD), Hepatic Steatosis, CT Severity Index (CTSI), Radiological Complications

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) may worsen the course of acute pancreatitis, yet evidence from regional settings is limited. Objective: To estimate the frequency of NAFLD among patients with acute pancreatitis and evaluate its association with radiological severity. Methods: A cross-sectional study was conducted in the department of Radiology, CMH Multan (June–December 2024). Consecutive adults (18–65 years) presenting within 24 hours and fulfilling clinical and biochemical criteria for acute pancreatitis underwent non-contrast abdominal computed tomography. NAFLD was defined by a liver-to-spleen attenuation ratio <1 with ≥10 Hounsfield Unit difference in individuals without alcohol use. Severity was graded using the CT Severity Index (CTSI). Results: Ninety-five patients were analyzed (61.1% male; mean age 42.3±13.7 years); NAFLD was present in 41/95 (43.2%). Compared with non-NAFLD, NAFLD cases had higher body mass index (29.2±4.1 vs 24.7±3.8 kg/m²; p<0.001) and more diabetes (41.5% vs 18.5%; p=0.014) and hypertension (46.3% vs 22.2%; p=0.016). Median amylase and lipase were higher in NAFLD (both p<0.001). Severity shifted toward higher CTSI categories with NAFLD (mild 26.8% vs 68.5%, moderate 48.8% vs 27.8%, severe 24.4% vs 3.7%; p<0.001); mean CTSI was 4.2±2.8 vs 2.1±1.9 (p<0.001). NAFLD was associated with moderate-to-severe pancreatitis (OR 4.83; 95% CI 2.14–10.91) and severe pancreatitis (OR 8.37; 95% CI 1.79–39.14). Radiological complications were more frequent with NAFLD: necrosis 31.7% vs 11.1% (p=0.015), peripancreatic fluid 58.5% vs 33.3% (p=0.018), pseudocyst 19.5% vs 5.6% (p=0.037). Findings were consistent across strata. Conclusions: NAFLD was common and associated with higher CTSI severity and local complications; routine CT assessment of hepatic steatosis may aid early risk stratification.

Downloads

Download data is not yet available.

References

1. Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73-84.

https://doi.org/10.1002/hep.28431

2. Spanier, B. W. M., Nio, Y., van der Hulst, R. W. M., Tuynman, H. A. R. E., Dijkgraaf, M. G. W., & Bruno, M. J. (2010). Practice and Yield of Early CT Scan in Acute Pancreatitis: A Dutch Observational Multicenter Study. Pancreatology, 10(2-3), 222–228.

https://doi.org/10.1159/000243731

3. Banks, P., Bollen, T., Dervenis, C., & Kinns, H. (2013). Classification of acute pancreatitis - 2012: Revision of the Atlanta classification and definitions by international concensus. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 50(2), 182-182.

https://doi.org/10.1177/0004563213480712

4. Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2017). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328-357.

https://doi.org/10.1002/hep.29367

5. Morel-Cerda, E. C., Velasco, J. A. V. R., Álvarez-López, F., García-Jiménez, E. S., Rangel-Orozco, M. F., González-Álvarez, R., ... & Aldana-Ledesma, J. M. (2019). Prevalence of fatty liver in patients with acute pancreatitis. Revista Médica MD, 9(2), 113-118.

https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=85135

6. Jia, J., Wu, Q., Kou, J., & Yang, M. (2018). Relationship between fatty liver and pancreatitis. International Journal of Clinical Medicine, 09(04), 243-248.

https://doi.org/10.4236/ijcm.2018.94021

7. Xu, C., Qiao, Z., Lu, Y., Zhang, D., Jia, Z., Zhuang, X., Shi, Y., Xu, T., Xing, L., & Shen, J. (2015). Influence of Fatty Liver on the Severity and Clinical Outcome in Acute Pancreatitis. PLOS ONE, 10(11), e0142278–e0142278.

https://doi.org/10.1371/journal.pone.0142278

8. Yoon, S. B., Lee, I. S., Choi, M. H., Lee, K., Ham, H., Oh, H. J., Park, S. H., Lim, C.-H., & Choi, M.-G. (2017). Impact of Fatty Liver on Acute Pancreatitis Severity. Gastroenterology Research and Practice, 2017, 1–7.

https://doi.org/10.1155/2017/4532320

9. Liu, W., Li, Z., Zhang, X., Du, J., Liang, R., Ji, Y., Tang, W., & Zhang, X. (2022). CT Characteristics of Acute Pancreatitis with Preexisting Fatty Liver and Its Impact on Pancreatitis Severity and Persistent Systemic Inflammatory Response Syndrome. International Journal of General Medicine, Volume 15, 7017–7028.

https://doi.org/10.2147/ijgm.s382287

10. Jiang, M., Zhang, M., Zhang, L., Luo, L., & Chen, Q. (2021). Impact of fatty liver on acute pancreatitis severity and prognosis. Radiology of Infectious Diseases, 8(4), 140-149.

https://doi.org/10.4103/rid.rid_10_22

11. Hou, S., Tang, X., Cui, H., Liu, C., Bai, X., Shi, L., & Shi, Y. (2019). Fatty liver disease is associated with the severity of acute pancreatitis:A systematic review and meta-analysis. International Journal of Surgery, 65, 147–153.

https://doi.org/10.1016/j.ijsu.2019.04.003

12. Zhu, L., Yuan, L., Wang, T., Zhu, Q., Zhang, Q., Pan, C., Xu, Q., Deng, D., Chen, W., & Chen, J. (2023). Relation between triglycerides and the severity of acute pancreatitis combined with nonalcoholic fatty liver disease: a retrospective study. BMC Gastroenterology, 23(1).

https://doi.org/10.1186/s12876-023-02951-9

13. Make, N. C., Yewale, R., Parthasarathy, G., Doraiswami, B. V., Jayaraman, K., Karthikeyan, D., & Ramakrishna, B. S. (2024). Association of Fatty Liver with Severity and Clinical Outcomes in Patients with Acute Pancreatitis: A Prospective Study from a Tertiary Care Center in South India. Gastroenterology Hepatology and Endoscopy Practice, 4(3), 87–94.

https://doi.org/10.4103/ghep.ghep_12_24

14. Khan, D., & Kashif, M. (2023). Fatty liver and acute pancreatitis severity: A prospective analysis utilizing computerized tomographic scan. International Journal of Health Sciences, 7065–7071.

https://doi.org/10.53730/ijhs.v6ns7.14042

15. Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global Epidemiology of Nonalcoholic Fatty Liver disease-Meta-analytic Assessment of prevalence, incidence, and Outcomes. Hepatology, 64(1), 73–84.

https://doi.org/10.1002/hep.28431

Downloads

Published

2025-05-30

How to Cite

Kakar, M. N., Khan Tareen, A., Kakar, R., Jamil, M. I., Bano, S., & Aziz, S. (2025). Frequency of Fatty Liver in Patients Presenting with Acute Pancreatitis and Its Association with Disease Severity. Indus Journal of Bioscience Research, 3(5), 971-975. https://doi.org/10.70749/ijbr.v3i5.2102